CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 119 filers reported holding CHEMOCENTRYX INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | +100.0% | 265 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | +40.0% | 265 | +29.9% | 0.00% | – |
| Q1 2022 | $5,000 | -28.6% | 204 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | +75.0% | 204 | -14.6% | 0.00% | – |
| Q3 2021 | $4,000 | +100.0% | 239 | +74.5% | 0.00% | – |
| Q2 2021 | $2,000 | -71.4% | 137 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | -12.5% | 137 | +5.4% | 0.00% | – |
| Q4 2020 | $8,000 | -61.9% | 130 | -66.6% | 0.00% | – |
| Q3 2020 | $21,000 | +61.5% | 389 | +18.2% | 0.00% | – |
| Q2 2020 | $13,000 | 0.0% | 329 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | 0.0% | 329 | 0.0% | 0.00% | – |
| Q4 2019 | $13,000 | +550.0% | 329 | -9.9% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 365 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 365 | +35.7% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 269 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | 0.0% | 269 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 269 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 269 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |